<DOC>
	<DOC>NCT00298831</DOC>
	<brief_summary>The primary purpose of the study is to determine the time-course of recovery to a T4/T1 ratio of 0.9 after a dose of sugammadex when administered at least 15 minutes after the last administration of rocuronium in a wide range of surgical procedures and anesthetic regimens (routine use). Safety evaluation is part of the study.</brief_summary>
	<brief_title>Use of Sugammadex at the End of Case in Routine Anesthesia (19.4.311)(P05943)</brief_title>
	<detailed_description />
	<mesh_term>Rocuronium</mesh_term>
	<criteria>Inclusion criteria: ASA Class 13 subjects who are scheduled to undergo an elective surgical procedure under general anesthesia requiring neuromuscular relaxation with the use of rocuronium. Exclusion criteria: Subjects with neuromuscular disorders, significant renal dysfunction, malignant hyperthermia, allergy to medications used in general anesthesia and in whom difficult intubation is expected. Subjects taking medications known to interfere with neuromuscular blocking agents. Subject who are of childbearing potential, pregnant, and breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>